par Maertens, J.;Glasmacher, Axel;Herbrecht, R;Thiebaut, Anne;Cordonnier, Catherine;Segal, Brahm H;Killar, John;Taylor, Arlene;Kartsonis, Nicholas;Patterson, Thomas F;Aoun, Michel
;Caillot, Denis;Sable, Carole;Caspofungin Combination Therapy Study Group,
Référence Cancer, 107, 12, page (2888-2897)
Publication Publié, 2006-12

Référence Cancer, 107, 12, page (2888-2897)
Publication Publié, 2006-12
Article révisé par les pairs
Titre: |
|
Auteur: | Maertens, J.; Glasmacher, Axel; Herbrecht, R; Thiebaut, Anne; Cordonnier, Catherine; Segal, Brahm H; Killar, John; Taylor, Arlene; Kartsonis, Nicholas; Patterson, Thomas F; Aoun, Michel; Caillot, Denis; Sable, Carole; Caspofungin Combination Therapy Study Group, |
Informations sur la publication: | Cancer, 107, 12, page (2888-2897) |
Statut de publication: | Publié, 2006-12 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Adult |
Antifungal Agents -- adverse effects -- therapeutic use | |
Aspergillosis -- drug therapy -- mortality | |
Drug Therapy, Combination | |
Echinocandins | |
Female | |
Humans | |
Male | |
Middle Aged | |
Peptides, Cyclic -- adverse effects -- therapeutic use | |
Recurrence | |
Salvage Therapy | |
Treatment Failure | |
Note générale: | Clinical Trial |
Journal Article | |
Multicenter Study | |
Research Support, Non-U.S. Gov't | |
FLWIN | |
Langue: | Anglais |
Identificateurs: | urn:issn:0008-543X |
info:doi/10.1002/cncr.22348 | |
info:pmid/17103444 |